Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design

This publication has 45 references indexed in Scilit:

• Chemotherapy of Chagas Disease: Status and New Developments
  Current Topics in Medicinal Chemistry, 2002
• Enzymes of the Trypanothione Metabolism as Targets for Antitrypanosomal Drug Development
  Current Topics in Medicinal Chemistry, 2002
• Chemotherapy of Chagas Disease
  Current Pharmaceutical Design, 2002
• Potent and specific inhibitors of trypanothione reductase from Trypanosoma cruzi: bis(2-aminodiphenylsulfides) for fluorescent labeling studies
  Bioorganic & Medicinal Chemistry, 2001
• 2- and 3-Substituted 1,4-Naphthoquinone Derivatives as Subversive Substrates of Trypanothione Reductase and Lipoamide Dehydrogenase from Trypanosoma cruzi: Synthesis and Correlation between Redox Cycling Activities and in Vitro Cytotoxicity
  Journal of Medicinal Chemistry, 2001
• Pharmacological Approaches to Antitrypanosomal Chemotherapy
  Memórias do Instituto Oswaldo Cruz, 1999
• Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: Effect on parasite intracellular survival
  Proceedings of the National Academy of Sciences, 1998
• Aromatic guanyl hydrazones: Synthesis, structural studies and in vitro activity against Trypanosoma cruzi
  Bioorganic & Medicinal Chemistry Letters, 1995
• Disulfide‐Reductase Inhibitors as Chemotherapeutic Agents: The Design of Drugs for Trypanosomiasis and Malaria
  Angewandte Chemie International Edition in English, 1995
• Thirteenfold increase of chromosomal aberrations non-randomly distributed in chagasic children treated with nifurtimox
  Mutation Research/Genetic Toxicology, 1989